Diabetic nephropathy: Focusing on pathological signals, clinical treatment, and dietary regulation
Year: 2023
Type: review
Abstract: Diabetic nephropathy (DN) is one of the most severe complications of diabetes. However, due to its complex pathological mechanisms, no effective therapeutic methods (other than ACEIs and ARBs) have been applied, which have been used for many years in clinical practice. Recent studies have shown that emerging therapeutics, including novel target-based pharmacotherapy, cell therapies, and dietary regulation, are leading to new hopes for DN management. This review aims to shed new light on the treatment of DN by describing the important pathological mechanisms of DN and by analysing recent advances in clinical treatment, including drug therapy, cell therapy, and dietary regulation. In pathological mechanisms, RAAS activation, AGE accumulation, and EMT are involved in inflammation, cellular stress, apoptosis, pyroptosis, and autophagy. In pharmacotherapy, several new therapeutics, including SGLT2 inhibitors, GLP-1 agonists, and MRAs, are receiving public attention. In addition, stem cell therapies and dietary regulation are also being emphasized. Herein, we highlight the importance of combining therapy and dietary regulation in the treatment of DN and anticipate more basic research or clinical trials to verify novel strategies.
Source: Biomedicine & Pharmacotherapy
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Keywords: diabetic nephropathy, diabetes complications, renin-angiotensin-aldosterone system, advanced glycation end products, epithelial-mesenchymal transition, inflammation, apoptosis, pyroptosis, autophagy, SGLT2 inhibitors, GLP-1 receptor agonists, mineralocorticoid receptor antagonists, ACE inhibitors, angiotensin receptor blockers, stem cell therapy, dietary regulation
Open Access status: gold
Estimated APC paid: $3,050
Award: G7812281912
OpenAlex ID: W4315926895
